# A Study of Risperidone Monotherapy in Bipolar Anxiety

> **NCT00167479** · PHASE4 · COMPLETED · sponsor: **University of South Florida** · enrollment: 60 (—)

## Conditions studied

- Bipolar Disorder
- Panic Disorder
- Generalized Anxiety Disorder

## Interventions

- **DRUG:** risperidone (Risperdal)

## Key facts

- **NCT ID:** NCT00167479
- **Lead sponsor:** University of South Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** —
- **Final completion:** 2006-09
- **Target enrollment:** 60 (—)
- **Last updated:** 2006-09-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00167479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00167479, "A Study of Risperidone Monotherapy in Bipolar Anxiety". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00167479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*